A Redefined Psychedelic Compound: Harmonizing Therapeutic Advantages with Diminished Side Effects<\/p>\n
In recent times, the therapeutic promise of psychedelic substances in addressing mental health issues such as depression, anxiety, and PTSD has generated considerable interest. However, the widely recognized hallucinogenic traits of these drugs come with certain unwanted side effects, including nausea and gastrointestinal distress, which are associated with the stimulation of serotonin receptors beyond the brain. Mitigating these negative effects is essential for ensuring the safe application of psychedelics in clinical environments.<\/p>\n
A research group at Virginia Commonwealth University, headed by Ma\u0142gorzata Dukat and Javier Gonz\u00e1lez-Maeso, has made a significant leap forward in this area by re-modifying the psychedelic substance, quipazine. Their objective was to create a compound analogous to quipazine that specifically targeted the serotonin 2A receptor without triggering the serotonin 3 receptor, which is linked to unpleasant side effects such as nausea.<\/p>\n
The team\u2019s methodology entailed systematically breaking down quipazine to determine the role of its structural components in receptor interaction. This breakdown enabled the scientists to pinpoint the nitrogen atom that binds to the serotonin 2A receptor. Utilizing previous findings on the serotonin 3 receptor, they altered quipazine\u2019s configuration by substituting its quinoline core with a quinazoline segment, adding an extra nitrogen atom. This modification led to the formation of VCU-1012, a compound that preserved quipazine\u2019s affinity for the serotonin 2A receptor while removing its activity at the serotonin 3 receptor.<\/p>\n
The newly formulated VCU-1012 showed encouraging outcomes during trials on mice displaying anxiety- and depression-related behaviors. The compound produced antidepressant-like effects without disrupting gastrointestinal function. Additionally, it enhanced the density of dendritic spines in the brain’s frontal cortex, promoting neural plasticity, a critical element in the enduring therapeutic impacts of psychedelics.<\/p>\n
While VCU-1012 is still in the preliminary preclinical phase, this innovation provides a potential framework for the development of structurally innovative psychedelics with improved therapeutic effectiveness and reduced side effects. Gonz\u00e1lez-Maeso is hopeful that this research could lead to future studies aimed at devising safer and more potent neuropsychiatric medications.<\/p>\n","protected":false},"excerpt":{"rendered":"
A Redefined Psychedelic Compound: Harmonizing Therapeutic Advantages with Diminished Side Effects In recent times, the therapeutic promise of psychedelic substances in addressing mental health issues such as depression, anxiety, and PTSD has generated considerable interest. However, the widely recognized hallucinogenic traits of these drugs come with certain unwanted side effects, including nausea and gastrointestinal distress, […]<\/p>\n","protected":false},"author":1,"featured_media":374446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[174],"class_list":["post-374445","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-source-chemistryworld-com"],"_links":{"self":[{"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/posts\/374445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=374445"}],"version-history":[{"count":0,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/posts\/374445\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=\/wp\/v2\/media\/374446"}],"wp:attachment":[{"href":"https:\/\/wolfscientific.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=374445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=374445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wolfscientific.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=374445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}